Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Hot wallets provide quick access for daily trades but are more exposed to online threats. This article covers ideal use cases and precautions.
17,534 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
No stock goes straight up, and Walmart’s latest report is a perfect example. Strong e-commerce gains meet a cautious ...
After more than a month of walkouts, the york nurses union wins a tentative contract with NewYork-Presbyterian that i...
Artificial intelligence is reshaping markets, but one big risk many investors fear may be overblown. This article exp...
A growing cohort of retirees is exploring a 5.5% withdrawal strategy as market conditions and Social Security plannin...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
RedotPay, a hong kong-based stablecoin payments company, is weighing a U.S. IPO that could raise more than $1 billion...
New data released this week shows Americans facing persistent affordability pressures. Three charts highlight afforda...
US regulators tighten safeguards on new crypto derivatives as Europe sharpens its enforcement. Crypto traders chasing...
Snowflake's Q4 2026 results set the tone for its growth path in 2027. This analysis breaks down the numbers, the AI-d...
Netflix is pivoting toward ads and international growth. This article breaks down the netflix's revenue expected surg...
IMAX stock is showing fresh strength after a solid quarterly beat and a clear path to bigger earnings from its premiu...